BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 38755568)

  • 1. MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment.
    Ornello R; Zelli V; Compagnoni C; Caponnetto V; De Matteis E; Tiseo C; Tessitore A; Sacco S
    J Headache Pain; 2024 May; 25(1):80. PubMed ID: 38755568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Use of Erenumab vs Nonspecific Oral Migraine Preventives: The APPRAISE Randomized Clinical Trial.
    Pozo-Rosich P; Dolezil D; Paemeleire K; Stepien A; Stude P; Snellman J; Arkuszewski M; Stites T; Ritter S; Lopez Lopez C; Maca J; Ferraris M; Gil-Gouveia R
    JAMA Neurol; 2024 May; 81(5):461-470. PubMed ID: 38526461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab.
    Al-Khazali HM; Ashina H; Christensen RH; Wiggers A; Rose K; Iljazi A; Amin FM; Ashina M; Snellman J; Maio-Twofoot T; Schytz HW
    Cephalalgia; 2024 Jun; 44(6):3331024241258734. PubMed ID: 38859744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can calcitonin gene-related peptide monoclonal antibodies ameliorate writer's cramp and migraine?
    Suzuki K; Suzuki S; Fujita H; Sakuramoto H; Shioda M; Hirata K
    Neuropsychopharmacol Rep; 2024 Jun; 44(2):482-484. PubMed ID: 38602109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies targeting the calcitonin gene-related peptide pathway improve the effectiveness of acute medication-a real-world study.
    Rosignoli C; Caponnetto V; Onofri A; Trozzi V; Tartaglione L; Silvestro M; Russo A; Sacco S; Ornello R
    Neurol Sci; 2024 Jul; 45(7):3305-3312. PubMed ID: 38340218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis.
    Fernández-Bravo-Rodrigo J; Cavero-Redondo I; Lucerón-Lucas-Torres M; Martínez-García I; Flor-García A; Barreda-Hernández D; Pascual-Morena C
    Eur J Pharmacol; 2024 Aug; 976():176702. PubMed ID: 38823758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crucial Role of microRNAs as New Targets for Amelogenesis Disorders Detection.
    Masunova N; Tereschenko M; Alexandrov G; Spirina L; Tarasenko N
    Curr Drug Targets; 2023; 24(14):1139-1149. PubMed ID: 37936447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentially expressed genes and miRNAs in female osteoporosis patients.
    Zhou H; Jiang J; Chen X; Zhang Z
    Medicine (Baltimore); 2022 Jul; 101(28):e29856. PubMed ID: 35839011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Markers in Melanoma Progression: A Study on the Expression of miRNA Gene Subtypes in Tumoral vs. Benign Nevi.
    Prodan M; Costescu S; Elagez A; Laitin SMD; Bloanca V; Crainiceanu Z; Seclaman E; Toma AO; Fericean RM; Puenea G; Cozma GV
    Curr Oncol; 2024 May; 31(5):2881-2894. PubMed ID: 38785501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive assessment of circulatory miRNAs as potential diagnostic markers in HCV recurrence post liver transplantation.
    Salum GM; Abd El Meguid M; Fotouh BE; Abdel Aziz AO; Dawood RM
    Diagn Microbiol Infect Dis; 2024 Jul; 109(3):116331. PubMed ID: 38692204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study.
    Wang SJ; Kim BK; Wang H; Zhou J; Wan Q; Yu T; Lian Y; Arkuszewski M; Ecochard L; Snellman J; Wen S; Yin F; Li Z; Su W; Yu S
    Headache; 2024 May; ():. PubMed ID: 38785393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs in association with pancreatic cancer risk within 5 years.
    Wang C; Cai H; Cai Q; Wu J; Stolzenberg-Solomon R; Guo X; Zhu C; Gao YT; Berlin J; Ye F; Zheng W; Setiawan VW; Shu XO
    Int J Cancer; 2024 Aug; 155(3):519-531. PubMed ID: 38602070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the microRNA-mRNA regulatory network associated with solasonine in bladder cancer.
    Fang K; Fang DL; Yu H; Chen YA; Yu PZ; Wang ZF; Zhang RB; Yang W; Tao L; Fukushima H; Dong Y; Han CH
    Transl Androl Urol; 2024 May; 13(5):812-827. PubMed ID: 38855608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migraine day frequency in migraine prevention: longitudinal modelling approaches.
    Di Tanna GL; Porter JK; Lipton RB; Brennan A; Palmer S; Hatswell AJ; Sapra S; Villa G
    BMC Med Res Methodol; 2019 Jan; 19(1):20. PubMed ID: 30674285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNome Profiling Analysis Reveals Novel Hepatocellular Carcinoma Diagnostic, Prognostic and Treatment-Related Candidate Biomarkers: Post hoc Analysis of SORAMIC Trial.
    Morkunas E; Vaitkeviciute E; Inciuraite R; Kupcinskas J; Link A; Skieceviciene J; Alunni-Fabbroni M; Schütte K; Malfertheiner P; Varkalaite G; Ricke J
    Dig Dis; 2024 Apr; ():1-13. PubMed ID: 38657585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression analysis in peripheral blood and soft-tissue of patients with periprosthetic hip infection.
    Paksoy A; Meller S; Schwotzer F; Moroder P; Trampuz A; Imiolczyk JP; Perka C; Hackl M; Plachel F; Akgün D
    Bone Jt Open; 2024 Jun; 5(6):479-488. PubMed ID: 38839054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation sequencing profiling of miRNAs in individuals with 22q11.2 deletion syndrome revealed altered expression of miR-185-5p.
    Dantas AG; Nunes BC; Nunes N; Galante P; Asprino PF; Ota VK; Melaragno MI
    Hum Genomics; 2024 Jun; 18(1):64. PubMed ID: 38872198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying the differentially expressed peripheral blood microRNAs in psychiatric disorders: a systematic review and meta-analysis.
    Liu X; Dong L; Jiang Z; Song M; Yan P
    Front Psychiatry; 2024; 15():1390366. PubMed ID: 38827444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation.
    Raffaelli B; Do TP; Ashina H; Snellman J; Maio-Twofoot T; Ashina M
    Cephalalgia; 2024 Jun; 44(6):3331024241259489. PubMed ID: 38850034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of lacosamide on calcitonin gene-related peptide serum level in episodic migraine patients: a randomized, controlled trial.
    Elgamal S; Ahmed SR; Nahas MM; Hendawy SR; Elshafei O; Zeinhom MG
    Acta Neurol Belg; 2024 Jun; 124(3):965-972. PubMed ID: 38502425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.